PACAP: A master regulator of neuroendocrine stress circuits and the cellular stress response

Annals of the New York Academy of Sciences

Volumn 1220, Issue 1, 2011, Pages 49-59

  Stroth, Nikolas ^a   Holighaus, Yvonne ^a   Ait Ali, Djida ^a   Eiden, Lee E ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

HPA axis; Hypothalamus; Neuropeptides; PACAP; Stress response

Indexed keywords

ADRENALIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GENE PRODUCT; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MESSENGER RNA; NEUROPEPTIDE; NEUROTRANSMITTER;

ADRENAL CORTEX; ADRENAL GLAND; ADRENAL MEDULLA; ARTICLE; CELL CULTURE; CELL STRAIN; CELLULAR STRESS RESPONSE; CENTRAL NERVOUS SYSTEM; GENETIC TRANSCRIPTION; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VIVO STUDY; METABOLIC STRESS; NERVE CELL; NERVE CELL MEMBRANE POTENTIAL; NERVOUS SYSTEM INJURY; NEUROENDOCRINE SYSTEM; NEUROPROTECTION; NEUROSECRETORY CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SYNAPSE; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; UPREGULATION;

MUS;

EID: 79952477473     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.05904.x     Document Type: Article

References (64)

1. Eiden, L.E. 2003. Signaling during exocytosis. In Handbook of Cell Signaling. Vol. 3. R. Bradshaw & E. Dennis, Eds.: 375-392. Academic Press. New York
2. Hökfelt, T., T. Bartfai & F. Bloom 2003. Neuropeptides: opportunities for drug discovery. Lancet Neurol. 2: 463-472.
3. Miyata, A. et al 1989. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164: 567-574.
4. Mustafa, T. & L.E. Eiden 2006. The secretin superfamily: PACAP, VIP and related peptides. In Handbook of Neurochemistry and Molecular Neurobiology: XIII. Neuroactive Peptides and Proteins. Vol. XIII. R. Lim, Ed.: 1-36. Springer. Heidelberg
5. Hansel, D.E. et al 2001. Pituitary adenylyl cyclase-activating peptides and alpha-amidation in olfactory neurogenesis and neuronal survival in vitro. J. Neurosci. 21: 4625-4636.
6. Seidah, N.G. et al 2008. The activation and physiological functions of the proprotein convertases. Int. J. Biochem. Cell Biol. 40: 1111-1125.
7. Li, M., M. Mbikay & A. Arimura 2000. Pituitary adenylate cyclase-activating polypeptide precursor is processed solely by prohormone convertase 4 in the gonads. Endocrinology 141: 3723-3730.
8. Feany, M.B. & W.G. Quinn 1995. A neuropeptide gene defined by the Drosophila memory mutant amnesiac. Science 268: 869-873.
9. Zhong, Y. 1995. Mediation of PACAP-like neuropeptide transmission by coactivation of Ras/Raf and cAMP signal transduction pathways in Drosophila. Nature 375: 588-592.
10. DiCicco-Bloom, E. et al 1998. The PACAP ligand/receptor system regulates cerebral cortical neurogenesis. Ann. N.Y. Acad. Sci. 865: 274-289.
11. Frechilla, D. et al 2001. BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neurons. Neuroreport 12: 919-923.
12. Nielsen, K.M. et al 2004. PACAP promotes sensory neuron differentiation: blockade by neurotrophic factors. Molec. Cell. Neurosci. 25: 629-641.
13. Vaudry, D. et al 1998. Pituitary adenylate cyclase-activating polypeptide stimulates both c-Fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience 84: 801-812.
14. May, V. et al 2010. Pituitary adenylate cyclase-activating polypeptide (PACAP)/PAC1HOP1 receptor activation coordinates multiple neurotrophic signaling pathways: Akt activation through phosphatidylinositol 3-kinase gamma and vesicle endocytosis for neuronal survival. J. Biol. Chem. 285: 9749-9761.
15. Deutsch, P.J. & Y. Sun 1992. The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J. Biol. Chem. 267: 5108-5113.
16. Falluel-Morel, A. et al 2007. The neuropeptide pituitary adenylate cyclase-activating polypeptide exerts anti-apoptotic and differentiating effects during neurogenesis: focus on cerebellar granule neurones and embryonic stem cells. J. Neuroendocrinol. 19: 321-327.
17. Vaudry, D. et al 2005. Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult. Peptides 26: 2518-2524.
18. Tanaka, J. et al 1997. Neuronal protection from apoptosis by pituitary adenylate cyclase-activating polypeptide. Regul. Pept. 72: 1-8.
19. Waschek, J.A. 1996. VIP and PACAP receptor-mediated actions on cell proliferation and survival. Ann. N.Y. Acad. Sci. 805: 290-300.
20. Mori, H. et al 2010. Cardioprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on doxorubicin-induced cardiomyopathy in mice. Circ. J. 74: 1183-1190.
21. Reglodi, D. et al 2001. Pituitary adenylate cyclase activating polypeptide is highly abundant in the nervous system of anoxia-tolerant turtle, Pseudemys scripta elegans. Peptides 22: 873-878.
22. Hamelink, C., E. Weihe & L.E. Eiden 2003. PACAP: an 'emergency response' co-transmitter in the adrenal medulla. In Pituitary Adenylate Cyclase-Activating Polypeptide. H. Vaudry & A. Arimura, Eds.: 227-250. Kluwer-Academic Press. Norwell, MA
23. Holgert, H. et al 1996. PACAP in the adrenal gland-relationship with choline acetyltransferase, enkephalin and chromaffin cells and effects of immunological sympathectomy. Neuroreport 20: 297-301.
24. Moller, K. & F. Sundler 1996. Expression of pituitary adenylate cyclase-activating peptide (PACAP) and PACAP type I receptors in the rat adrenal medulla. Regul. Pept. 63: 129-139.
25. Hamelink, C. et al 2002. Pituitary adenylate cyclase activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Proc. Natl. Acad. Sci. U.S.A. 99: 461-466.
26. Stroth, N. & L.E. Eiden 2010. Stress hormone synthesis in mouse hypothalamus and adrenal gland triggered by restraint is dependent on pituitary adenylate cyclase-activating polypeptide signaling. Neuroscience 165: 1025-1030.
27. Kvetnansky, R. et al 1995. Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann. N.Y. Acad. Sci. 771: 131-158.
28. Ait-Ali, D. et al 2010. Neuropeptides, growth factors and cytokines: a cohort of informational molecules whose expression is up-regulated by the stress-associated slow transmitter PACAP in chromaffin cells. Cell. Mol. Neurobiol. 30: 1441-1449.
29. Zhang, K.Z. et al 1998. High expression of stanniocalcin in differentiated brain neurons. Am. J. Pathol. 153: 439-445.
30. Zhang, K. et al 2000. Stanniocalcin: a molecular guard of neurons during cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 97: 3637-3642.
31. Teplova, V. et al 2004. Differentiated Paju cells have increased resistance to toxic effects of potassium ionophores. Acta. Biochim. Pol. 51: 539-544.
32. Koizumi, K. et al 2007. Stanniocalcin 1 prevents cytosolic Ca2+ overload and cell hypercontracture in cardiomyocytes. Circ. J. 71: 796-801.
33. Westberg, J.A. et al 2007. Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart. Am. J. Physiol. Heart Circ. Physiol. 293: H1766-H1771.
34. Westberg, J.A. et al 2007. Hypoxic preconditioning induces neuroprotective stanniocalcin-1 in brain via IL-6 signaling. Stroke 38: 1025-1030.
35. Vaudry, D. et al 2002. Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP). J. Neurochem. 83: 1272-1284.
36. Eiden, L.E. et al 2008. Discovery of PACAP-related genes through microarray analyses in cell culture and in vivo. Ann. N.Y. Acad. Sci. 1144: 6-20.
37. Ravni, A. et al 2008. A cAMP-dependent, PKA-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells. Mol. Pharmacol. 73: 1688-1708.
38. Hamelink, C. et al 2002. Coincident elevation of cyclic AMP and calcium influx by PACAP-27 synergistically regulates VIP gene transcription through a novel PKA-independent signaling pathway. J. Neurosci. 22: 5310-5320.
39. Papanikolaou, N.A. & E.L. Sabban 1999. Sp1/Egr1 motif: a new candidate in the regulation of rat tyrosine hydroxylase gene transcription by immobilization stress. J. Neurochem. 73: 433-436.
40. Kageyama, K. et al 2007. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells. J. Endocrinol. 195: 199-211.
41. Hashimoto, H. et al 2001. Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc. Natl. Acad. Sci. U.S.A. 98: 13355-13360.
42. Otto, C. et al 2001. Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Brain Res. Mol. Brain Res. 92: 78-84.
43. Chen, Y. et al 2004. Expression profiling of cerebrocortical transcripts during middle cerebral artery occlusion and treatment with pituitary adenylate cyclase-activating polypeptide (PACAP) in the mouse. In Pharmacology of Cerebral Ischemia. J. Krieglstein & S. Klumpp, Eds.: 267-277. Medpharm Scientific Publishers. Stuttgart, Germany
44. Chen, Y. et al 2006. Neuroprotection by endogenous and exogenous PACAP following stroke. Regul. Pept. 137: 4-19.
45. Reglodi, D. et al 2002. Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia. Peptides 23: 2227-2234.
46. Ohtaki, H. et al 2006. Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc. Natl. Acad. Sci. U.S.A. 103: 7488-7493.
47. Goldstein, D.S. 2010. Adrenal responses to stress. Cell Mol. Neurobiol. 30: 1433-1440.
48. Kvetnansky, R., E.L. Sabban & M. Palkovits 2009. Catecholaminergic systems in stress: structural and molecular genetic approaches. Physiol. Rev. 89: 535-606.
49. Sabban, E.L. et al 2004. Molecular regulation of gene expression of catecholamine biosynthetic enzymes by stress: sympathetic ganglia versus adrenal medulla. Ann. N.Y. Acad. Sci. 1018: 370-377.
50. Liu, X. et al 2008. Identifying the stress transcriptome in the adrenal medulla following acute and repeated immobilization. Ann. N.Y. Acad. Sci. 1148: 1-28.
51. Nankova, B.B. et al 2000. Fos-related antigen 2: potential mediator of the transcriptional activation in rat adrenal medulla evoked by repeated immobilization stress. J. Neurosci. 20: 5647-5653.
52. Nankova, B.B. & E.L. Sabban 1999. Multiple signalling pathways exist in the stress-triggered regulation of gene expression for catecholamine biosynthetic enzymes and several neuropeptides in the rat adrenal medulla. Acta Physiol. Scand. 167: 1-9.
53. Papanikolaou, N.A. & E.L. Sabban 2000. Ability of Egr1 to activate tyrosine hydroxylase transcription in PC12 cells. J. Biol. Chem. 275: 26683-26689.
54. Legradi, G., J. Hannibal & R.M. Lechan 1998. Pituitary adenylate cyclase-activating polypeptide-nerve terminals densely innervate corticotropin-releasing hormone-neurons in the hypothalamic paraventricular nucleus of the rat. Neurosci. Lett. 246: 145-148.
55. Agarwal, A., L.M. Halvorson & G. Legradi 2005. Pituitary adenylate cyclase-activating polypeptide (PACAP) mimics neuroendocrine and behavioral manifestations of stress: evidence for PKA-mediated expression of the corticotropin-releasing hormone (CRH) gene. Brain Res. Mol. Brain Res. 138: 45-57.
56. Grinevich, V., A. Fournier & G. Pelletier 1997. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain Res. 773: 190-196.
57. Hannibal, J. 2002. Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J. Comp. Neurol. 453: 389-417.
58. Hannibal, J. et al 1999. PACAP gene expression in neurons of the rat hypothalamo-pituitary-adrenocortical axis is induced by endotoxin and interleukin-1beta. Neuroendocrinology 70: 73-82.
59. Girard, B.M. et al 2002. Regulation of neurotrophic peptide expression in sympathetic neurons: quantitative analysis using radioimmunoassay and real-time quantitative polymerase chain reaction. Regul. Pept. 109: 89-101.
60. Elenkov, I. J. et al 2000. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52: 595-638.
61. Kvetnansky, R. et al 1998. Stressor specificity of peripheral catecholaminergic activation. Adv. Pharmacol. 42: 556-560.
62. Hammack, S.E. et al 2009. Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology 34: 833-843.
63. Hammack, S.E. et al 2010. Roles for pituitary adenylate cyclase-activating peptide (PACAP) expression and signaling in the bed nucleus of the stria terminals (BNST) in mediating the behavioral consequences of chronic stress. J. Mol. Neurosci. 42: 327-340.
64. Sawchenko, P.E., H.Y. Li & A. Ericsson 2000. Circuits and mechanisms governing hypothalamic responses to stress: a tale of two paradigms. Prog. Brain Res. 122: 61-78.